153 related articles for article (PubMed ID: 23910403)
1. Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence.
Islam J; Cheek E; Navani V; Rajkumar C; Cohen J; Llewelyn MJ
J Hosp Infect; 2013 Sep; 85(1):17-21. PubMed ID: 23910403
[TBL] [Abstract][Full Text] [Related]
2. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
3. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
[TBL] [Abstract][Full Text] [Related]
5. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Clostridium difficile infection is associated with increased mortality.
Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
[TBL] [Abstract][Full Text] [Related]
7. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
10. Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients.
Shah K; Pass LA; Cox M; Lanham M; Arnold FW
J Trauma Acute Care Surg; 2012 Mar; 72(3):691-5. PubMed ID: 22491554
[TBL] [Abstract][Full Text] [Related]
11. The appendix may protect against Clostridium difficile recurrence.
Im GY; Modayil RJ; Lin CT; Geier SJ; Katz DS; Feuerman M; Grendell JH
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1072-7. PubMed ID: 21699818
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes associated with severe clostridium difficile infection in children.
Kim J; Shaklee JF; Smathers S; Prasad P; Asti L; Zoltanski J; Dul M; Nerandzic M; Coffin SE; Toltzis P; Zaoutis T
Pediatr Infect Dis J; 2012 Feb; 31(2):134-8. PubMed ID: 22031485
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
[TBL] [Abstract][Full Text] [Related]
15. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
16. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.
Hensgens MP; Goorhuis A; Dekkers OM; Kuijper EJ
J Antimicrob Chemother; 2012 Mar; 67(3):742-8. PubMed ID: 22146873
[TBL] [Abstract][Full Text] [Related]
17. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
18. Potential protective role of linezolid against Clostridium difficile infection.
Valerio M; Pedromingo M; Muñoz P; Alcalá L; Marin M; Peláez T; Giannella M; Bouza E
Int J Antimicrob Agents; 2012 May; 39(5):414-9. PubMed ID: 22445203
[TBL] [Abstract][Full Text] [Related]
19. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ
Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
